AMIT INDRAVADAN SHAH M.D. NPI 1407850449

NPI Information

  • NPI: 1407850449
  • Provider Name: AMIT INDRAVADAN SHAH, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1396 WHISPER CIR
    SEBRING, FL
    ZIP 33870
  • Phone: (863) 385-1244

Map and Directions

Get Directions

NPI Details

Amit Indravadan Shah, M.D. is a medical oncology internal medicine in Sebring, FL with 48 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Amit Indravadan Shah, M.D. NPI is 1407850449. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1396 WHISPER CIR
SEBRING, FL
ZIP 33870-204
Phone: (863) 385-1244

The NPI 1407850449 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Iron level (HCPCS:83540)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Iron binding capacity (HCPCS:83550)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Protein measurement, serum (HCPCS:84165)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Magnesium level (HCPCS:83735)
  • Folic acid level, serum (HCPCS:82746)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Automated urinalysis test (HCPCS:81003)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)

The enumeration date for this NPI number is 6/8/2005 and was last updated on 9/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyME48069FLORIDANo
2207RX0202XInternal MedicineMedical OncologyME48069FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1045758200MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.